MedTrace Logo

Remote Rapid Onsite Evaluation (ROSE) for Head and Neck Fine Needle Aspirations (FNA)

NCT05962944 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2023-08-01

No results posted yet for this study

Summary

Rapid On-Site Evaluation (ROSE) of cytology FNA samples performed by a Pathologist or Biomedical Scientist is a real time morphological assessment of the sample in the clinical setting with the aim of acquiring all the diagnostic material in one appointment resulting in reduction in costs, improved patient care and reduced referral to treatment time.

It is not practical or possible for the ROSE team to be present in every location where an FNA is performed. Telecytology (TC) or remote ROSE is a digital form of ROSE which allows a biomedical scientist or pathologist working in a remote laboratory to review the cytology slides in real time, using microscope images fed from the location where the FNA procedure is being performed.

Conditions

  • Head and Neck Neoplasms

Interventions

DEVICE

Olympus Cellsens software

Olympus cellsens software will be used to visualise the cells and MS teams screen share will be used to send the live images in real time.

Sponsors & Collaborators

  • Royal Cornwall Hospitals Trust

    lead OTHER

Principal Investigators

  • Leonie Wheeldon · Royal Cornwall Hospital

Eligibility

Min Age
18 Years
Max Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-25
Primary Completion
2023-06-15
Completion
2023-07-24

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05962944 on ClinicalTrials.gov